
Acting FDA commissioner calls for independent investigation into approval of Alzheimer's drug
CNN
US Food and Drug Administration Acting Commissioner Dr. Janet Woodcock on Friday requested an investigation by the US Department of Health and Human Services Office of Inspector General into the controversial approval of the Alzheimer's disease drug Aduhelm.
In a letter posted on Twitter, Woodcock said an independent review and assessment should consider interactions between Biogen, the company that makes Aduhelm, and the FDA during the process that led to the June approval of the drug.
Defense Secretary Pete Hegseth risked compromising sensitive military information that could have endangered US troops through his use of Signal to discuss attack plans, a Pentagon watchdog said in an unclassified report released Thursday. It also details how Hegseth declined to cooperate with the probe.

Two top House lawmakers emerged divided along party lines after a private briefing with the military official who oversaw September’s attack on an alleged drug vessel that included a so-called double-tap strike that killed surviving crew members, with a top Democrat calling video of the incident that was shared as part of the briefing “one of the most troubling things” he has seen as a lawmaker.











